Palatin Technologies
PTN
#9923
Rank
โ‚น3.52 B
Marketcap
โ‚น2,068
Share price
4.59%
Change (1 day)
2,525.34%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚น1.47 Billion

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.43 Billion, an increase over its 2023 earnings that were of -โ‚น2.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น1.47 Billion-39.44%
2024 -โ‚น2.43 Billion-16.9%
2023 -โ‚น2.92 Billion5.99%
2022 -โ‚น2.75 Billion-13.7%
2021 -โ‚น3.19 Billion33.25%
2020 -โ‚น2.4 Billion-172.11%
2019 โ‚น3.31 B2352.33%
2018 โ‚น0.13 B-94.13%
2017 โ‚น2.30 B-154.92%
2016 -โ‚น4.2 Billion3.67%
2015 -โ‚น4.05 Billion878%
2014 -โ‚น0.42 Billion-72.64%
2013 -โ‚น1.52 Billion-33.11%
2012 -โ‚น2.27 Billion77.71%
2011 -โ‚น1.28 Billion
2003 -โ‚น2.16 Billion29.93%
2002 -โ‚น1.66 Billion36.18%
2001 -โ‚น1.22 Billion
1999 -โ‚น1.02 Billion6.04%
1998 -โ‚น0.96 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚น1.07 Billion-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚น2.66 Billion 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น52.42 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น4.54 B-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น6.00 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.58 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.912 T-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5 Billion 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.176 T-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK